A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia Centers.
Maria Grazia Rumi(University of Milan), P.M. Mannucci(Ospedale L. Bonomo), Giuseppe Tagariello(Ospedale Castelfranco Veneto), Massimo Morfini, Elena Santagostino(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), A. Tagger(University of Milan), Antonio Chistolini(Sapienza University of Rome), Patrizia Pontisso(University of Padua), A. Gringeri(Beth Israel Deaconess Hospital), Massimo Colombo(University of Milan)
Cited by 55
Related Papers
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|494
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
|Hepatology|2012|405
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394